$ENOB

Enochian Biosciences Inc

  • NASDAQ
  • Finance
  • Financial Conglomerates
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$2.6 -

Extented Hours

VOLUME

144,157

DAY RANGE

2.52 - 2.93

52 WEEK

1.42 - 13.78

Join Discuss about ENOB with like-minded investors

profile
@maletone #StockTraders.NET
recently

$ENOB just nasty

92 Replies 9 πŸ‘ 12 πŸ”₯

BR
@brAli #StockTraders.NET
recently

trch wish ENob

114 Replies 14 πŸ‘ 6 πŸ”₯

profile
@maletone #StockTraders.NET
recently

Atlas got bent on $ENob

53 Replies 7 πŸ‘ 13 πŸ”₯

profile
@Math #StockTraders.NET
recently

$ENOB thanks for playing

145 Replies 11 πŸ‘ 15 πŸ”₯

profile
@Chano #StockTraders.NET
recently

a year ago did a similar move > @TraderXx said: $ENOB expecting a blow off ver highs and a sit back right after

98 Replies 6 πŸ‘ 14 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$ENOB expecting a blow off ver highs and a sit back right after

145 Replies 13 πŸ‘ 14 πŸ”₯

BR
@brAli #StockTraders.NET
recently

$enob monster move

139 Replies 11 πŸ‘ 8 πŸ”₯

profile
@viking #StockTraders.NET
recently

Upside: -ENOB +159% (announces FDA Acceptance of Pre-IND Request for Potential HIV Cure) -ITOS +51% (GSK and iTeos announce development and commercialisation collaboration for EOS-448) -CRSR +15% (hearing interest from WallStreetBets) -NVAX +9.0% (COVID-19 vaccine demonstrates 90% overall efficacy and 100% protection against moderate and severe disease in PREVENT-19 Phase 3 trial) -LPCN +8.3% (FDA clears LPCN 1154 IND application for a Phase 2 Postpartum Depression Study) -RIOT +8.3% (crypto strength following TSLA CEO Musk indicating car maker may resume BTC transactions) -HAPP +7.8% (signed agreement to distribute Volkswagen Electric Vehicles) -MARA +7.8% (crypto strength following TSLA CEO Musk indicating car maker may resume BTC transactions) -RAPT +7.7% (reports positive topline results from Phase 1b Trial of RPT193 Monotherapy in Atopic Dermatitis) -AMTX +6.0% (signs $200M biofuels offtake agreement with international renewable fuels supplier Murex, LLC to be delivered during 2021 to 2023) -OCC +5.4% (earnings) -EFOI +4.8% (enters marketing partnership with FirstEnergy Home and FirstEnergy Advisors) -TWST +3.2% (collaborates with Regeneron for production of genotyping by sequencing panel to enable diverse genome-wide screening) -HGEN +2.8% (initiates Submission for Lenzilumab Marketing Authorization in COVID-19, to the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA)) -CODA +2.3% (earnings) -OTLK +2.3% (announces inclusion in the Russell 2000 Index, effective June 25, 2021) -SVOK +1.1% (confirms Boxed to go public through merger with Seven Oaks Acquisition Corp. in deal valued at ~$900M) Downside: -ATXI -47% (receives Complete Response Letter from the FDA for IV Tramadol, saying it does not support benefits as a monotherapy) -RIDE -11% (CEO and CFO resign following results of special committee investigation of Hindenburg Research report) -HEXO -3.6% (earnings) -NKLA -1.5% (discloses entered into a purchase agreement and a registration rights agreement with Tumim Stone Capital to sell $300M of the Nikola's common stock)

112 Replies 14 πŸ‘ 15 πŸ”₯

profile
@thegiz18 #ivtrades
recently

$ENOB big jump on FDA accepting an application to test a new HIV drug.

94 Replies 10 πŸ‘ 10 πŸ”₯

profile
@Chano #StockTraders.NET
recently

were you long or short on $APOP? the float scared me out and I couldn't find dilution so I stayed away > @Math said: $APOP $ENOB $CSCW $RAIL were much easier names

78 Replies 15 πŸ‘ 10 πŸ”₯

profile
@Math #StockTraders.NET
recently

$APOP $ENOB $CSCW $RAIL were much easier names

90 Replies 8 πŸ‘ 15 πŸ”₯

Key Metrics

Market Cap

146.67 M

Beta

1.30

Avg. Volume

89.36 K

Shares Outstanding

52.95 M

Yield

0%

Public Float

0

Next Earnings Date

2022-09-23

Next Dividend Date

Company Information

Enochian BioSciences is a biopharmaceutical company dedicated to identifying, developing, manufacturing, and commercializing gene-modified cell therapy. Our gene-modified cell therapy platform can be applied to multiple indications including HIV/AIDS, HBV and Oncology.

Website:

HQ: ,

Related News